Mutant GTF2I was harbored in ~20%–90% of the tumor cells among all the thymomas (Figure 1), suggesting a high cellular prevalence of mutant GTF2I. This GTF2I mutation appeared to trigger clonal expansion and is retained ubiquitously within the tumors of the same clone. This evidence concerns the gene GTF2I and neoplasm.